arrow
A

Ahmad H. Ali

university of missouri
H指数:21
被引数:2,445

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling

肠道菌群衍生的咪唑丙酸盐通过p38信号通路促进原发性硬化性胆管炎

2026-09-040
OA
Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis

维生素B6预测地理上不同人群的原发性硬化性胆管炎的不良结局

2026-04-170
OAAI
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward

口服万古霉素用于原发性硬化性胆管炎及其相关炎症性肠病——铺就前进之路

2026-03-100
PRE
Plasma Biomarkers of Senescence in Cholestatic Liver Disease: A Signature of Risk Stratification and Progression

胆汁淤积性肝病中衰老的血浆生物标志物:风险分层和进展的标志物

2026-02-130
PRE
The application of EUS-guided portal pressure gradient measurement with concomitant EUS-liver elastography and EUS-guided liver biopsy in patients with chronic liver disease: a single center experience

EUS引导下门静脉压力梯度测量联合EUS肝脏弹性成像和EUS引导下肝活检在慢性肝病患者的应用:单中心经验

2025-07-300
OA
Comment on Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis

关于口服万古霉素治疗与原发性硬化性胆管炎相关的炎症性肠病的效果与安全性:一项系统评价和合并分析

2025-04-210
OA
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer
2024-07-240
OAAI
A Model Incorporating Serum Alkaline Phosphatase for Prediction of Liver Fibrosis in Adults with Obesity and Nonalcoholic Fatty Liver Disease

结合血清碱性磷酸酶预测肥胖和非酒精性脂肪肝病成人肝纤维化的模型

2021-07-279
OAAI
Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation
2021-06-1556
OAAI